SELLAS Life Sciences Group, Inc. (SLS)

CIK 1390478 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for SELLAS Life Sciences Group, Inc..

Recent SEC filings

FiledFormAccession number
Aug 11, 20268-K0001390478-26-000013
Aug 11, 202610-Q0001390478-26-000012
Aug 7, 2026SCHEDULE 13G0000093751-26-000539
Jul 31, 2026SCHEDULE 13G0002100119-26-001315
Jul 27, 20268-K0001104659-26-087110
Jun 25, 20268-K0001104659-26-077556
Jun 18, 20268-K0001104659-26-075775
Jun 18, 202640001104659-26-075773
Jun 16, 2026S-80001104659-26-074599
Jun 2, 20268-K0001104659-26-069251
May 12, 202610-Q0001390478-26-000008
May 12, 20268-K0001390478-26-000009
Apr 24, 2026SCHEDULE 13G/A0002012383-26-001466
Apr 23, 2026ARS0001104659-26-047704
Apr 23, 2026DEFA14A0001104659-26-047697
Apr 23, 2026DEF 14A0001104659-26-047693
Mar 27, 2026SCHEDULE 13G/A0000102909-26-002236
Mar 20, 2026S-3ASR0001104659-26-032776
Mar 19, 202610-K0001390478-26-000003
Mar 19, 20268-K0001390478-26-000004
Mar 11, 20268-K0001104659-26-026384
Feb 17, 2026SCHEDULE 13G/A0001193125-26-053508
Jan 30, 2026SCHEDULE 13G/A0000902664-26-000615
Jan 9, 202640001104659-26-002509
Jan 9, 202640001104659-26-002515